share_log

HOOKIPA Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Orlinger Klaus

HOOKIPA Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Orlinger Klaus

HOOKIPA Pharma | 4：持股变动声明-高管 Orlinger Klaus
美股sec公告 ·  04/17 16:20
Moomoo AI 已提取核心信息
Klaus Orlinger, the Chief Scientific Officer of HOOKIPA Pharma Inc. [HOOK], was involved in a transaction with the company's stock on April 15, 2024. Unfortunately, the announcement does not provide details such as the action type, action status, number of shares, nature of shares, transaction price, number of shares held after the action, or the total value of shares. Without this information, the impact of the transaction on Orlinger's holdings and the market cannot be assessed.
Klaus Orlinger, the Chief Scientific Officer of HOOKIPA Pharma Inc. [HOOK], was involved in a transaction with the company's stock on April 15, 2024. Unfortunately, the announcement does not provide details such as the action type, action status, number of shares, nature of shares, transaction price, number of shares held after the action, or the total value of shares. Without this information, the impact of the transaction on Orlinger's holdings and the market cannot be assessed.
HOOKIPA Pharma Inc. [HOOK] 的首席科学官克劳斯·奥林格于2024年4月15日参与了该公司股票的交易。不幸的是，该公告没有提供诸如行动类型、行动状态、股票数量、股票性质、交易价格、行动后持有的股票数量或股票总价值等细节。没有这些信息，就无法评估该交易对Orlinger持股和市场的影响。
HOOKIPA Pharma Inc. [HOOK] 的首席科学官克劳斯·奥林格于2024年4月15日参与了该公司股票的交易。不幸的是，该公告没有提供诸如行动类型、行动状态、股票数量、股票性质、交易价格、行动后持有的股票数量或股票总价值等细节。没有这些信息，就无法评估该交易对Orlinger持股和市场的影响。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息